Get started
Author

María San Román

Observed names: M. San Roman-Gil, M.V. San Roman Gil, Maria San Román, Maria San-Roman-Gil, Maria San‑Roman‑Gil, María San Román Gil, María San Román-Gil, María San-Román-Gil
ORCID: 0000-0002-8810-6525
Observed ORCID: 0000-0002-8810-6525
OpenAlex ID: A5081030703
Adoptive T cell therapy for solid tumors: current landscape and future challenges
2024 · Víctor Albarrán, María San Román, et al. · Frontiers in Immunology · 121
PDF
Tyrosine Kinase Receptors in Oncology
2020 · Jorge Esteban-Villarrubia, Juan José Soto-Castillo, et al. · International Journal of Molecular Sciences · 107
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma
2021 · Pablo Álvarez Ballesteros, Jesús Chamorro, et al. · Cancers · 80
PDF
BRAF Mutated Colorectal Cancer: New Treatment Approaches
2020 · Javier Molina-Cerrillo, María San Román, et al. · Cancers · 80
PDF
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas
2022 · Víctor Albarrán, María Luisa Villamayor, et al. · International Journal of Molecular Sciences · 38
PDF
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
2022 · María San Román-Gil, Javier Pozas, et al. · Cancer Treatment Reviews · 38
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
2024 · Víctor Albarrán, Patricia Guerrero, et al. · Cancer Immunology Immunotherapy · 35
PDF
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
2022 · Víctor Albarrán, Diana Isabel Rosero, et al. · International Journal of Molecular Sciences · 34
PDF
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
2023 · María San-Román-Gil, Javier Torres-Jiménez, et al. · Cancers · 30
PDF
Current Landscape of Immunotherapy for Advanced Sarcoma
2023 · Víctor Albarrán, María Luisa Villamayor, et al. · Cancers · 28
PDF
BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature
2023 · Patricia Guerrero, Víctor Albarrán, et al. · Cancers · 25
PDF
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms
2019 · Javier Pozas, María San Román, et al. · International Journal of Molecular Sciences · 25
PDF
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
2025 · Jaume Capdevila, Virginia Pubul, et al. · BMC Cancer · 18
PDF
Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy
2020 · María San Román Gil, Javier Pozas, et al. · International Journal of Molecular Sciences · 17
PDF
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
2021 · Javier Torres-Jiménez, Víctor Albarrán-Fernández, et al. · International Journal of Molecular Sciences · 15
PDF
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations
2022 · Javier Pozas, Teresa Alonso-Gordoa, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 13
Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients
2024 · Patricia Guerrero, Víctor Albarrán, et al. · The Oncologist · 10
PDF
Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature
2024 · María San-Román-Gil, Iñigo Martínez-Delfrade, et al. · Frontiers in Immunology · 5
PDF
Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature
2023 · Víctor Albarrán, Jesús Chamorro, et al. · Frontiers in Oncology · 5
PDF
From bench to bedside: the development journey of fruquintinib as a colorectal cancer therapy
2025 · María San-Román-Gil, Lucrezia Zumstein, et al. · Expert Opinion on Drug Discovery · 1
Perioperative chemotherapy and long-term cure in resected grade 3 gastroenteropancreatic neuroendocrine carcinomas: The GETNE SOUTH-NEC Study
2026 · Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, et al. · European Journal of Cancer
Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
2026 · Jaume Capdevila, Virginia Pubul, et al. · BMC Cancer
PDF
1162P Transcriptomic analysis of gastroenteropancreatic neuroendocrine tumours with carcinoid syndrome
2024 · J. Pozas Perez, T. Alonso Gordoa, et al. · Annals of Oncology
PDF
Impact of steroids indication on the efficacy of immunotherapy in a multi-tumor cohort of patients: Time and dose-dependent evaluation.
2024 · Pablo Gajate, Victor Albarrán, et al. · Journal of Clinical Oncology
PDF
Spinal Intramedullary Ewing Sarcoma with Meningeal Carcinomatosis: A Complete Response to Chemotherapy and Neuroaxis Irradiation. Case Report and Review of Literature
2023 · Víctor Albarrán, María Luisa Villamayor, et al. · Journal of Cancer Science and Clinical Therapeutics
Works count: 27
Citation count: 725
H-index: 15
I10-index: 17
Year
Topic
Type